Ingevity €590 million acquisition of Capa

12/12/2018

Private acquisition

Value:

€ 595 million

Dollar value:

$ 675 million

Status:

Announced

Date:

12/12/2018

Overview:

Ingevity has acquired Capa from Perstorp for €590 million.
Capa is Perstorp's UK based caprolactone business.

Prin Shasiharan - Researcher

Jurisdictions:

Sweden
United Kingdom

Deal type:

Private acquisition

Practice area:

M&A

Industry sector:

Industrials and manufacturing

Firms:

Allen & Overy

Party: Perstorp (Seller)

Lawyer: Stephen Lloyd

Eversheds Sutherland

Party: Ingevity (Acquirer)

Mannheimer Swartling

Party: Perstorp (Seller)

Lawyer: Anders Lückander

Related deals